Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include Revuforj ® (revumenib), an ...
Intel's stock is down after Lip-Bu Tan failed to offer quick fixes in a recent speech. But analysts saw positive aspects to his approach in the new role. Intel Corp. Chief Executive Lip-Bu Tan just ...
18h
Barchart on MSNAnalysts Say the ‘Anti Elon Musk Crowd’ Will Hurt Tesla in the ‘Near Term.’ Should You Buy or Sell TSLA Stock Here?Tesla (TSLA) has always been a company that sparks both excitement and debate, and its recent challenges have only added fuel ...
Intel's (INTC) new CEO Lip-Bu Tan outlining his priorities helped stakeholders understand the company's intended positioning ...
Stifel analyst Ruben Roy notes that Lip Bu Tan addressed the Intel (INTC) Vision 2025 Opening Keynote, outlining his top priorities after two ...
Tesla faces challenges from Elon Musk backlash, affecting sales forecasts. Stifel cuts price target to $455 but retains Buy ...
Stifel Sun Valley Finals The World Cup Ski Finals concluded yesterday in historic Sun Valley, Idaho. The first destination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results